CLINICAL_TRIALS
trial_result
· 2021-09-14
Clinical Trial Update: A Study of Safety and Tolerability in Subjects With Schizophrenia [Phase 1]
Summary
Phase 1 trial assessing safety and tolerability in subjects with schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Denovo Biopharma LLC | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2021-09-14